Injectable vs Oral BPC-157: Which Option Delivers Better Results
They may appear as bluish bumps and often cause discomfort
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
High dose: severe injuries or serious arthritis (only under the supervision of a veterinarian) Capsule-based protocols also make use of: Dogs more than 75 lbs: 500 mcg per day to twice per day
[2] If symptoms are severe or persistent, it's important to discuss them with your healthcare professional
